Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Mupirocin to Prevent Staphylococcal Infection
NCT00108160Phase 4Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Apr 2005
- Primary completion
- Aug 2012
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in staphylococcal infection comparing Mupirocin Ointment with Placebo Ointment (2 arms). Primary endpoint: Re-infection With S. Aureus at 18 months. Started Apr 2005; status: completed.
02
Drugs
mupirocin
03
Conditions
staphylococcal infection
Beyond the preview
Go deeper on NCT00108160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108160.